HIGH-LEVELS OF INTERLEUKIN-10 DURING THE INITIAL PHASE OF FULMINANT MENINGOCOCCAL SEPTIC SHOCK

被引:110
作者
DERKX, B
MARCHANT, A
GOLDMAN, M
BIJLMER, R
VANDEVENTER, S
机构
[1] EMMA KINDER ZIEKENHUIS,CHILDRENS ACAD MED CTR,DEPT PEDIAT INTENS CARE,1105 AZ AMSTERDAM,NETHERLANDS
[2] ACAD MED CTR,CTR HEMOSTASIS ATHEROSCLEROSIS & INFLAMMAT RES,AMSTERDAM,NETHERLANDS
[3] FREE UNIV BRUSSELS,HOP ERASME,DEPT IMMUNOL,B-1070 BRUSSELS,BELGIUM
关键词
D O I
10.1093/infdis/171.1.229
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin (IL)-10 has an important antiinflammatory effect by inhibiting endotoxin-induced production of proinflammatory cytokines, such as tumor necrosis factor-alpha and IL-1. Since both cytokines are produced in massive amounts during fulminant meningococcal septic shock and are associated with severity of disease, IL-10 was measured in plasma samples of 25 consecutive children with fulminant meningococcal septic shock shortly after admittance to a pediatric intensive care unit. High levels of IL-10 (median, 6021 pg/mL; range, 137-24,600) were found in surviving patients (median, 1268 pg/mL; range, 137-24,600) and in those who died (median, 9915 pg/mL; range, 3996-14,100). IL-10 levels correlated weakly (r = .38; P = .055) with severity of disease as measured by the Glasgow meningococcal septicemia prognostic score. The findings indicate that IL-10 is produced in massive amounts in the initial phase of fulminant meningococcal septic shock.
引用
收藏
页码:229 / 232
页数:4
相关论文
共 15 条
  • [1] MACROPHAGE DEACTIVATION BY INTERLEUKIN-10
    BOGDAN, C
    VODOVOTZ, Y
    NATHAN, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) : 1549 - 1555
  • [2] PLASMA ENDOTOXIN AS A PREDICTOR OF MULTIPLE ORGAN FAILURE AND DEATH IN SYSTEMIC MENINGOCOCCAL DISEASE
    BRANDTZAEG, P
    KIERULF, P
    GAUSTAD, P
    SKULBERG, A
    BRUUN, JN
    HALVORSEN, S
    SORENSEN, E
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) : 195 - 204
  • [3] FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
  • [4] INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA
    GERARD, C
    BRUYNS, C
    MARCHANT, A
    ABRAMOWICZ, D
    VANDENABEELE, P
    DELVAUX, A
    FIERS, W
    GOLDMAN, M
    VELU, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 547 - 550
  • [5] INTERLEUKIN-10 PROTECTS MICE FROM LETHAL ENDOTOXEMIA
    HOWARD, M
    MUCHAMUEL, T
    ANDRADE, S
    MENON, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) : 1205 - 1208
  • [6] MALEFYT RD, 1991, J EXP MED, V174, P1209
  • [7] MALEFYT RD, 1993, J IMMUNOL, V151, P6370
  • [8] INTERLEUKIN-10 PRODUCTION DURING SEPTICEMIA
    MARCHANT, A
    DEVIERE, J
    BYL, B
    DEGROOTE, D
    VINCENT, JL
    GOLDMAN, M
    [J]. LANCET, 1994, 343 (8899) : 707 - 708
  • [9] INTERLEUKIN-10 CONTROLS INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR PRODUCTION DURING EXPERIMENTAL ENDOTOXEMIA
    MARCHANT, A
    BRUYNS, C
    VANDENABEELE, P
    DUCARME, M
    GERARD, C
    DELVAUX, A
    DEGROOTE, D
    ABRAMOWICZ, D
    VELU, T
    GOLDMAN, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (05) : 1167 - 1171
  • [10] INTERLEUKIN-10 INHIBITS THE INDUCTION OF MONOCYTE PROCOAGULANT ACTIVITY BY BACTERIAL LIPOPOLYSACCHARIDE
    PRADIER, O
    GERARD, C
    DELVAUX, A
    LYBIN, M
    ABRAMOWICZ, D
    CAPEL, P
    VELU, T
    GOLDMAN, M
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (10) : 2700 - 2703